Legal & General Group PLC Cassava Sciences Inc Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Legal & General Group PLC holds 50,576 shares of SAVA stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,576

Previous 50,576 -0.0%

Holding current value

$1.36 Million

Previous $1.49 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.57 - $35.08 $11,407 - $41,815	-1,192 Reduced 2.3%	50,576 $1.49 Million
Q2 2024 Aug 14, 2024	BUY	$12.35 - $26.11 $120,350 - $254,441	9,745 Added 23.19%	51,768 $639,000
Q1 2024 May 14, 2024	BUY	$18.44 - $26.41 $22,293 - $31,929	1,209 Added 2.96%	42,023 $852,000
Q4 2023 Feb 15, 2024	BUY	$12.64 - $30.11 $41,939 - $99,904	3,318 Added 8.85%	40,814 $918,000
Q3 2023 Nov 14, 2023	BUY	$16.64 - $25.32 $1,098 - $1,671	66 Added 0.18%	37,496 $623,000
Q2 2023 Aug 14, 2023	BUY	$21.59 - $27.88 $6,584 - $8,503	305 Added 0.82%	37,430 $917,000
Q1 2023 May 15, 2023	BUY	$23.46 - $36.44 $59,518 - $92,448	2,537 Added 7.33%	37,125 $895,000
Q4 2022 Feb 14, 2023	SELL	$27.82 - $44.16 $3,978 - $6,314	-143 Reduced 0.41%	34,588 $1.02 Million
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $5,960 - $18,636	365 Added 1.06%	34,731 $1.45 Million
Q2 2022 Aug 22, 2022	SELL	$17.22 - $38.47 $14,120 - $31,545	-820 Reduced 2.33%	34,366 $966,000
Q1 2022 May 16, 2022	BUY	$32.6 - $53.05 $40,391 - $65,728	1,239 Added 3.65%	35,186 $1.31 Million
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $5,589 - $13,818	152 Added 0.45%	33,947 $1.48 Million
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $1.04 Million - $3.36 Million	24,849 Added 277.77%	33,795 $2.1 Million
Q2 2021 Aug 12, 2021	BUY	$32.15 - $89.72 $191,549 - $534,551	5,958 Added 199.4%	8,946 $765,000
Q1 2021 May 17, 2021	SELL	$7.09 - $87.95 $538 - $6,684	-76 Reduced 2.48%	2,988 $134,000
Q4 2020 Feb 12, 2021	BUY	$6.79 - $12.25 $4,807 - $8,673	708 Added 30.05%	3,064 $21,000
Q3 2020 Nov 13, 2020	SELL	$2.86 - $11.51 $2,579 - $10,382	-902 Reduced 27.69%	2,356 $27,000
Q2 2020 Aug 14, 2020	BUY	$2.04 - $9.64 $6,646 - $31,407	3,258 New	3,258 $10,000

Others Institutions Holding SAVA

# of Institutions

207

Shares Held

14M

Call Options Held

2.98M

Put Options Held

6.57M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $1.08B
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Cassava Sciences Inc Transaction History